Proyecto Miaplacidus

Biotechnology lab with proprietary products and manufacturing contracts

Automatically translatedSee original

Description

Biotechnology company with GMP facility, portfolio of seven proprietary products and manufacturing contracts for third parties in Europe. Sustained double-digit growth, registered industrial property and stable scientific team. Majority sale operation with founder reinvestment. Sample announcement with fictitious data.

Key facts

Sector
Pharma & Biotech
Area
Catalonia, Spain
Revenue
€25M – €50M
EBITDA
€2.5M – €5M
Deal type
Majority sale
Published
October 30, 2026

Approximate area

For confidentiality, we only show the autonomous community.

Price - On request

Interested in this company?

A Fundenza advisor will be in touch shortly to discuss the deal with you.

Anonymous listing reviewed by Fundenza